Graphite India BUY. Performance Highlights CMP. `93 Target Price `124. 4QFY2012 Result Update Capital Goods. Investment Period 12 Months

Similar documents
Graphite India BUY. Performance Highlights. CMP Target Price `88 `109. 1QFY2012 Result Update Capital Goods

SpiceJet BUY. Performance Highlights CMP. `32 Target Price `43. 1QFY2013 Result Update Airlines. Investment Period 12 Months.

KEI Industries BUY. Performance Update. CMP Target Price `433 `508. 4QFY2018 Result Update Cable. Historical share price chart.

KEI Industries BUY. Performance Update. Target Price. 3QFY2018 Result Update Cable. Historical share price chart. Key Financials

Mahindra & Mahindra Ltd.

ACC NEUTRAL. Performance Highlights. CMP `1,261 Target Price - 4QCY2012 Result Update Cement. Quarterly results (Standalone) Investment Period -

Goodyear India ACCUMULATE. Performance Highlights. CMP Target Price `326 `374. 1QCY2012 Result Update Tyres. Key financials

ITC ACCUMULATE. Performance Highlights CMP. `257 Target Price `284. 3QFY2017 Result Update FMCG. Investment Period 12 Months

MRF BUY. Performance Highlights. CMP `9,407 Target Price `11,343. Company Update Automobile. Key financials

GAIL India NEUTRAL. Performance Highlights CMP. `363 Target Price - 2QFY2013 Result Update Oil & Gas. Investment Period -

Ambuja Cements NEUTRAL. Performance Highlights CMP. `184 Target Price - 2QCY2012 Result Update Cement. Quarterly results (Standalone)

Ambuja Cements NEUTRAL. Performance Highlights CMP. `155 Target Price - 1QCY2011 Result Update Cement. Investment Period - Key financials (Standalone)

Century Plyboards Ltd

Quick take. Aditya Birla Nuvo BUY. Deep Value. Valuation Methodology. Exhibit 1: ABNL s Business Structure

Cairn India ACCUMULATE. Performance Highlights. CMP Target Price `338 `382. 2QFY2013 Result Update Oil & Gas. Quarterly highlights (Consolidated)

Simplex Infrastructures

Parag Milk Foods BUY. Performance Update CMP. `256 Target Price `330. 2QFY2019 Result Update Dairy Products. Investment Period 12 Months

Blue Star Ltd BUY. Performance Update. CMP Target Price `754 `867. 4QFY2018 Result Update Cons. Durable. 3-year price chart.

Mahindra & Mahindra Ltd.

TV Today Network BUY. Performance Update CMP. `323 Target Price `498. 3QFY2019 Result Update Media. Investment Period 12 Months

Mahindra & Mahindra Ltd.

Matrimony.com Ltd BUY. Performance Update. Target Price `1,016. 4QFY2018 Result Update Cable. Historical share price chart.

Coal India ACCUMULATE. Performance Highlights CMP. `338 Target Price `380. Outlook and valuation. 2QFY2016 Result Update Mining

BGR Energy Systems NEUTRAL. Performance Highlights CMP. `235 Target Price - 3QFY2013 Result Update Capital Goods. Investment Period -

Garware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months

Rallis India NEUTRAL. Performance Highlights CMP. `237 Target Price - 1QFY2018 Result Update Agrichemical. Investment Period - 3-year price chart

Parag Milk Foods BUY. Performance Update CMP. `324 Target Price `410. 1QFY2019 Result Update Dairy Products. Investment Period 12 Months

Maruti Suzuki India BUY. Performance Update. CMP `9,315 Target Price `10,820. 1QFY2019 Result Update Automobile. Historical share price chart

Rallis India NEUTRAL. Performance Highlights CMP. `215 Target Price - 3QFY2017 Result Update Agrichemical. Investment Period - 3-year price chart

Hindustan Media Ventures

Prakash Industries BUY. Performance Highlights. CMP Target Price `81 `124. 3QFY2011 Result Update Steel

Amber Enterprises India Ltd

Maruti Suzuki India BUY. Performance Update. CMP `6,705 Target Price `8,552. 2QFY2019 Result Update Automobile. Historical share price chart

Bata India BUY. Performance Update. CMP Target Price `842. 1QFY2019 Result Update Footwear. Historical share price chart.

Tata Steel NEUTRAL. Performance Highlights CMP. `226 Target Price - 2QFY2016 Result Update Steel. Investment Period - 3-year price chart

Rallis India NEUTRAL. Performance Highlights CMP. `242 Target Price - 4QFY2017 Result Update Agrichemical. Investment Period - 3-year price chart

Asian Granito BUY. Performance Highlights CMP. `270 Target Price `351. Outlook and valuation. 3QFY2017 Result Update Ceramics

Ambuja Cements ACCUMULATE. Performance Highlights. CMP Target Price `207 `233. 3QCY2015 Result Update Cement. Quarterly results (Standalone)

Goodyear India BUY. Company Update. CMP Target Price `515 `631. Company Update Tyres. 3-year Daily Price Chart. Key Financials

CCL Products BUY. Performance Update. CMP Target Price `278 `360. 3QFY2018 Result Update Coffee. Historical share price chart.

GMM Pfaudler Limited BUY. Performance Update CMP. `945 Target Price ` QFY2019 Result Update Industrial Machinery. Investment Period 12 Months

TVS Motor Company BUY. Performance Highlights. CMP Target Price `39 `45. 2QFY2013 Result Update Automobile. Quarterly highlights (Standalone)

Procter & Gamble Hygiene & Health Care

ACC BUY. Performance Highlights. CMP `1,397 Target Price `1,630. 3QCY2015 Result Update Cement

JK Lakshmi Cement BUY. Performance Highlights CMP. `63 Target Price `79. 4QFY2012 Result Update Cement. Investment Period 12 Months

SpiceJet ACCUMULATE. Performance Highlights. 4QFY2010 Result Update I Aviation

Hero MotoCorp NEUTRAL. Performance Highlights. CMP `2,245 Target Price - 4QFY2012 Result Update Automobile. Investment Period - Key financials

Hero MotoCorp ACCUMULATE. Performance Highlights. CMP `3,226 Target Price `3,466. 3QFY2017 Result Update Automobile. 3-year price chart

Bata India BUY. Performance Update. CMP `1,008 Target Price `1,243. 2QFY2019 Result Update Footwear. Historical share price chart.

Alembic BUY. Performance Highlights. Target Price. 1QFY2011 Result Update Pharmaceutical. Investment Period 12 months

Amara Raja Batteries BUY. Performance Highlights. CMP `1,010 Target Price `1,167. 2QFY2017 Result Update Auto Ancillary. 3-year price chart

SUN TV Network NEUTRAL. Performance Highlights CMP. `297 Target Price - 1QFY2013 Result Update Media. Investment Period -

Music Broadcast BUY. Performance Update. CMP Target Price `329 `475. 2QFY2019 Result Update Media. Historical share price chart.

Music Broadcast BUY. Performance Update. CMP Target Price `293 `475. 3QFY2019 Result Update Media. Stock Info Sector Market Cap (Rs cr) Media

Hero MotoCorp ACCUMULATE. Performance Highlights. CMP `3,718 Target Price `4,130. 1QFY2018 Result Update Automobile. 3-year price chart

HT Media ACCUMULATE. Performance Highlights CMP. `102 Target Price `113. 3QFY2013 Result Update Media. Investment Period 12 months

TV Today Network BUY. Performance Update. CMP Target Price `315 `385. 2QFY2017 Result Update Media. Historical share price chart.

Cadila Healthcare ACCUMULATE. Performance Highlights. CMP 860 Target Price QFY2013 Result Update Pharmaceutical. Key financials (Consolidated)

MRF BUY. Performance Highlights. CMP `40,703 Target Price `47,548. 1QSY2015 Result Update Tyre

Simplex Infrastructures

Blue Star Ltd BUY. Performance Update. CMP Target Price `703 `867. 1QFY2019 Result Update Cons. Durable. 3-year price chart.

Rallis India SELL. Performance Highlights. `231 Target Price 189 CMP. 2QFY2018 Result Update Agrichemical. Investment Period 12 months

Apollo Tyres BUY. Performance Highlights. CMP Target Price `71 `82. 4QFY2011Result Update Tyre. Key financials (Consolidated)

Quick take. Ruchira Papers Ltd. BUY. Creating value through paper. Target Price. Investment Period 12 Months. 3 year daily price chart.

Tech Mahindra ACCUMULATE. Performance Highlights. CMP Target Price `659 `693. 3QFY2012 Result Update IT. Key financials (Consolidated, Indian GAAP)

Greenply Industries BUY. The plywood maker for growing India. Target Price. Initiating Coverage Plywood. 3-year price chart.

Jindal Steel & Power BUY. CMP Target Price `200 `320. 1QFY2019 Result Update Steel & Power. Performance Update

Reliance Communication

Inox Wind BUY. Performance Highlights. CMP Target Price `390 `505. 2QFY2016 Result Update Capital Goods. 3 year price chart

Advisory Desk. TVS Srichakra Ltd. BUY CMP. `355 Target Price `468. Investment rationale. Outlook and valuation. Investment Period 12 Months

Sesa Goa NEUTRAL. Performance Highlights CMP. `372 Target Price - 2QFY2011 Result Update Mining. Investment Period -

ITD Cementation India

BGR Energy Systems ACCUMULATE. Performance Highlights CMP. `482 Target Price `520. 4QFY2011 Result Update Capital Goods. Investment Period 12 Months

Inox Wind BUY. Performance Highlights. CMP Target Price `242 `286. 4QFY2016 Result Update Capital Goods. 3 year price chart

Thermax NEUTRAL. Performance Highlights CMP. `673 Target Price - 3QFY2011 Results Update Capital Goods. Investment Period -

Sanofi India NEUTRAL. Performance Highlights. CMP `4,007 Target Price - 3QCY2017 Result Update Pharmaceutical. Investment Period 12 months

Hindalco NEUTRAL. Performance highlights CMP. `112 Target Price - 1QFY2013 Result Update Base Metals. Investment Period -

SUN TV Network NEUTRAL. Performance Highlights CMP. `369 Target Price - 2QFY2013 Result Update Media. Investment Period -

LT Foods BUY. Performance Update. CMP Target Price `76 `128. 4QFY2018 Result Update Media

Sanofi India NEUTRAL. Performance Highlights. CMP `4,007 Target Price - 2QCY2017 Result Update Pharmaceutical. 3-year price chart.

Colgate-Palmolive ACCUMULATE. Performance Highlights. 4QFY2010 Result Update I FMCG

LT Foods BUY. Performance Update. CMP Target Price `92 `128. 3QFY2018 Result Update Media February 12, 2018

Aurobindo Pharma BUY. Performance Highlights CMP. `109 Target Price `156. 1QFY2013 Result Update Pharmaceutical. Investment Period 12 months

Nestle India NEUTRAL. Performance Highlights. CMP `4,387 Target Price - 2QCY2012 Result Update FMCG. Quarterly results. Investment Period -

Apollo Tyres BUY. Performance Highlights. CMP Target Price `56 `65. 3QFY2011Result Update Tyre. Key Financials (Consolidated)

HFC NEUTRAL. Performance Highlights CMP. `678 Target Price - 1QFY2013 Result Update HFC. Investment Period - Key financials

Tech Mahindra ACCUMULATE. Performance Highlights CMP. `955 Target Price `1,070. 2QFY2013 Result Update IT. Investment Period 12 months

Cipla BUY. Performance Highlights CMP. `310 Target Price `369. 2QFY2012 Result Update Pharmaceutical. Investment Period 12 months

Cadila Healthcare NEUTRAL. Performance Highlights CMP. `495 Target Price - 4QFY2017 Result Update Pharmaceutical.

Mahindra & Mahindra BUY. CMP Target Price `860 `990. Company Update Automobile

Lupin NEUTRAL. Performance Highlights CMP. `448 Target Price - 2QFY2011 Result Update Pharmaceutical. Investment Period -

Maruti Suzuki ACCUMULATE. Performance Highlights. CMP `7,622 Target Price `8,501. 1QFY2018 Result Update Automobile

Quick take. Ashok Leyland Ltd BUY. Scrappage policy to drive faster growth. Target Price. Investment Period 12 Months. 3-year price chart

Sanofi India NEUTRAL. Performance Highlights. CMP `4,301 Target Price - 4QCY2016 Result Update Pharmaceutical. Investment Period - 3-year price chart

Container Corporation of India

KPIT Cummins ACCUMULATE. Performance Highlights CMP. `121 Target Price `132. 2QFY2013 Result Update IT. Investment Period 12 Months

Sun Pharma NEUTRAL. Performance Highlights CMP. 1QFY2013 Result Update Pharmaceutical. `676 Target Price - Investment Period -

Sanofi India ACCUMULATE. Performance Highlights. CMP `4,410 Target Price `4,738. 1QCY2016 Result Update Pharmaceutical. 3-year price chart

Transport Corporation of India

United Phosphorus REDUCE. Performance Highlights CMP. 1QFY2018 Result Update Agrichemical. Investment Period 12 months. 3-year price chart

Transcription:

4QFY2012 Result Update Capital Goods May 11, 2012 Graphite India Performance Highlights Y/E March (` cr) 4QFY2012 3QFY2012 % chg (qoq) 4QFY2011 % chg (yoy) Net sales 452 437 3.5 304 48.6 EBITDA 83 90 (7.7) 60 37.9 EBITDA (%) 18.3 20.5 (222)bp 19.7 (142)bp PAT 103 56 83.3 45 131.2 For 4QFY2012, Graphite India s (GIL) top line came in at `452cr, registering 48.6% yoy growth. EBITDA margin contracted by 142bp yoy to 18.3%. EBITDA increased by 37.9% yoy to `83cr. PAT increased by 131% to `103cr on the back of higher revenue, forex gain and higher other income. Going ahead, the scenario is positive for the company, as it has started steel production again in June 2011 (post the shutdown) and is showing a strong rising trend. We maintain our Buy view on the stock. Strong sales growth momentum continues: GIL reported strong sales growth in 4QFY2012. The company s revenue increased by 48.6% yoy to `452cr. The graphite segment, which contributed around 85.3% to the company s total revenue, registered strong growth of 52.9% yoy to `386cr, while the steel segment managed a whopping 150% yoy increase to `24cr. The company s OPM declined by 142bp yoy to 18.3% due to increased raw-material cost, which grew to 51.2% in 4QFY2012 as a percentage of sales vs. 50.5% in 4QFY2011. PAT increased by 131% yoy to `103cr, largely due to forex gain of `30cr and other income of `22cr during the quarter. Adjusted for other income and forex gain, PAT increased by 77.7% yoy. PAT margin also expanded significantly by 813bp yoy to 22.8% due to the above reason and prior-period tax adjustments resulting in lower tax rate. Tax rate declined to 12.5% of PBT in 4QFY2012 vs. 29.3% of PBT in 4QFY2011. Outlook and valuation: We remain positive on the prospects of GIL, owing to strong demand from steel manufacturers. Realizations are also set to increase, as global players have hiked their prices recently. We expect GIL to post a 12.2% CAGR in revenue over FY2012 14E and PAT to witness a 13.6% CAGR over the same period. At the CMP, the stock is trading at attractive valuations of 0.9x its FY2014E BV, respectively. We have valued the stock at its five-year median of 1.2x one-year forward book value to arrive at a target price of `124. We maintain our Buy recommendation on the stock. Key financials (Consolidated) Y/E March (` cr) FY2011 FY2012 FY2013E FY2014E Net Sales 1,444 1,912 2,158 2,406 % chg 7.2 32.5 12.8 11.5 Net Profit 189 212 243 274 % chg (19.5) 12.4 14.2 13.1 EBITDA Margin (%) 21.4 16.9 18.1 18.9 FDEPS (`) 9.7 10.9 12.4 14.0 P/E (x) 9.6 8.5 7.5 6.6 P/BV (x) 1.2 1.1 1.0 0.9 RoE (%) 13.5 13.4 14.0 14.3 RoACE (%) 14.4 12.9 13.9 15.8 EV/Sales (x) 1.5 1.1 0.9 0.8 EV/EBITDA (x) 6.9 6.5 5.1 4.0 BUY CMP `93 Target Price `124 Investment Period 12 Months Stock Info Sector Capital Goods Market Cap (`cr) Beta 52 Week High / Low Avg. Daily Volume 1,812 0.7 100/65 28,056 Face Value (`) BSE Sensex Nifty Reuters Code 2 16,293 4,929 GRPH.BO Bloomberg Code GRIL@IN Shareholding Pattern (%) Promoters 62.2 MF / Banks / Indian Fls 4.9 FII / NRIs / OCBs 16.9 Indian Public / Others 16.0 Abs.(%) 3m 1yr 3yr Sensex (8.2) (12.3) 39.5 Graphite 18.4 (3.4) 130.1 Sharan Lillaney +91 22 3935 7800 Ext: 6811 Sharanb.lillaney@angelbroking.com Please refer to important disclosures at the end of this report 1

Exhibit 1: 4QFY2012 performance highlights Y/E March (` cr) 4QFY2012 3QFY2012 % chg (qoq) 4QFY2011 % chg (yoy) FY2012 FY2011 % chg Net Sales 452.2 437.1 3.5 304.3 48.6 1,912 1,444 32.5 Consumption of RM 231.5 236.4 (2.1) 153.6 50.8 775 535 45.0 (% of Sales) 51.2 54.1 (288)bp 50.5 74bp 40.5 37.0 350bp Staff Costs 27.9 26.3 6.0 21.7 28.6 156 131 19.4 (% of Sales) 6.2 6.0 15bp 7.1 (96)bp 8.2 9.1 (89)bp Other Expenses 110.0 84.7 29.9 69.1 59.3 658 470 40.0 (% of Sales) 24.3 19.4 495bp 22.7 163bp 34.4 32.6 18 bp Total Expenditure 369.4 347.4 6.3 244.3 51.2 1,589 1,136 40.0 Operating Profit 82.8 89.7 (7.7) 60.0 37.9 323 308 4.8 OPM 18.3 20.5 (222)bp 19.7 (142)bp 16.9 21.4 (446)bp Interest 5.8 3.2 81.6 2.8 109.0 19 8 140.4 Depreciation 10.8 9.9 8.2 9.8 10.0 49 49 0.2 Other Income 21.9 6.2 253.2 15.6 40.5 38 34 10.6 PBT (excl. Extr. Items) 88.1 82.8 6.4 63.0 39.7 294 286 2.6 Extr. Income/(Expense) 29.6 - - 3 (13) PBT (incl. Extr. Items) 117.7 82.8 42.2 63.0 86.7 297 274 8.6 (% of Sales) 26.0 18.9 20.7 15.5 19.0 Provision for Taxation 14.8 26.6 (44.5) 18.5 (20.3) 85 85 0.2 (% of PBT) 12.5 32.1 29.3 28.5 30.9 Reported PAT 103.0 56.2 83.3 44.5 131.2 212 189 12.4 PATM 22.8 12.9 992bp 14.6 813bp 11.1 13.1 (199)bp Equity shares (cr) 19.5 19.5 17.1 19.5 17.1 EPS (`) 5.3 2.9 83.3 2.6 102.3 10.9 11.1 (1.7) Adjusted PAT 51.4 50.0 3bp 29.0 77.7% 178 142 25bp Segment-wise performance During the quarter, the graphite and carbon segment posted a 52.9% yoy increase in its revenue to `386cr. The segment posted EBIT margin of 13.7%, down 615bp yoy and 891bp qoq. Electrode sales volumes during the quarter grew by 51% yoy. The steel segment s sales increased by 150% yoy to `24cr. The segment reported profit of `5.5cr at the EBIT level in 4QFY2012 compared to profit of `7.0cr in 4QFY2011. The power segment posted a 13.0% yoy decline in revenue to `9cr. Generation of power at hydro electrical plants is seasonal in nature. EBIT margin of the segment came in at 60.8% in 4QFY2012. During the quarter, the company witnessed increased input costs other than needle coke. Average capacity utilization increased to 105% in 4QFY2012 from 91% in 4QFY2011. May 11, 2011 2

Exhibit 2: Segment-wise performance Y/E March (` cr) 4QFY2012 3QFY2012 4QFY2011 % chg (qoq) % chg (yoy) Total Revenue A) Graphite & Carbon 386 373 252 3.4 52.9 B) Power 9 8 10 17.1 (13.0) C) Steel 24 30 10 (17.6) 150.1 D) Others 49 37 44 33.6 11.0 Total 469 448 317 4.7 47.9 Less: Inter-Segmental Revenue 16 12 13 42.6 30.4 Net Sales 452 436 304 3.7 48.6 EBIT Margin (%) A) Graphite & Carbon 13.7 22.6 19.8 (891)bp (615)bp B) Power 60.8 73.8 67.0 (1,297)bp (614)bp C) Steel 48.0 3.1 (6.3) 4,485bp 5,423bp D) Others 23.3 10.9 28.6 1,241bp (530)bp Strong revenue growth at 48.6% yoy GIL has been maintaining a strong growth rate in its sales over the past few quarters. In 4QFY2012, the company s top line increased by 48.6% yoy to `452cr. The graphite segment, which contributed around 85.3% to the company s total revenue, registered strong growth of 52.9% yoy to `386cr, while the steel segment managed a whopping 150% yoy increase to `24cr. This performance was primarily due to increased graphite electrode price realizations in rupee terms, coupled with significantly higher volumes. Electrode sales volumes increased by 51% yoy during the quarter while production increased by 16% yoy. Exhibit 3: Sales trend (` cr) 500 450 400 350 300 250 200 150 100 50 0 258 324 337 304 319 462 437 452 60 50 40 30 20 (%) 10 0 (10) (20) 1QFY11 2QFY11 3QFY11 4QFY11 1QFY12 2QFY12 3QFY12 4QFY12 Sales (LHS) yoy Growth (RHS) May 11, 2011 3

EBITDA margin down on the back of higher input cost The company s EBITDA increased by 37.9% yoy to `83cr on the back of higher revenue during the quarter. OPM declined by 142bp yoy during the quarter to 18.3%. The decline was due to a substantial increase in raw-material costs during the quarter. We expect the company s OPM to increase in the coming quarters, with the steel division contributing to the top line again and currency stabilizing at current levels. Exhibit 4: OPM trend (` cr) 100 90 80 70 60 50 40 30 20 10 0 23.0 26.1 21.7 19.7 19.3 16.4 20.5 18.3 30 25 20 15 10 5 0 1QFY11 2QFY11 3QFY11 4QFY11 1QFY12 2QFY12 (%) 3QFY12 4QFY12 EBITDA (LHS) OPM (RHS) PAT up by 131% yoy on the back of other income and forex gains PAT increased by 131% yoy to `103cr, largely due to other income of `22cr and forex gain of `30cr during the quarter. Adjusted for other income and forex gain, PAT increased by 77.7% yoy. PAT margin also expanded significantly by 813bp yoy to 22.8% due to the above reason and prior-period tax adjustments resulting in lower tax rate. Tax rate declined to 12.5% of PBT in 4QFY2012 vs. 29.3% of PBT in 4QFY2011. The company sold its entire stake in CINV, a wholly owned subsidiary, during the quarter for `30cr. Exhibit 5: PAT trend 120 100 103 80 60 40 34 49 44 45 37 42 56 20 0 1QFY11 2QFY11 3QFY11 4QFY11 1QFY12 (` cr) 2QFY12 3QFY12 4QFY12 May 11, 2011 4

Investment arguments GIL set to ride on the industry's rebound: The graphite electrodes industry is expected to grow faster, compared to EAF steel production over the next few years, as the de-stocking of graphite electrodes inventory at the steel manufacturers end is expected to reverse. GIL, with capacity expansion from 78,000mt/year to 98,000mt/year, to be completed by FY2012E, is well poised to reap the benefits of this growth. Strong labor cost advantages: GIL has strong labor cost advantages compared to its global peers, as other companies have their plants at locations where labor costs are significantly higher compared to India. SGL Carbon SE, the largest global player, has plants located mainly across Europe and North America. GrafTech Ltd., the world s second largest player, has plants located in France, Spain, South Africa, Brazil and Mexico. In FY2011, GIL's employee cost was ~9% of sales, whereas it was almost 27% (CY2010) for SGL. Historically, GIL has passed on a part of this advantage to gain market share. However, with the rate of market share addition expected to slow down, we expect GIL to retain a larger part of this cost advantage and, thereby, improve its margins over historically average levels. Strong entry barriers: The global graphite electrodes industry is characterized by a high level of consolidation, with the top six players accounting for over 70% of the world s total installed capacity. The balance capacity is owned by motley of small players. The highly consolidated nature of the industry is due to the barriers for new entrants. For instance, only the top global players have the technology to manufacture high-quality ultra high power (UHP) graphite electrodes. The industry is marked by a relationship and referral-based model. A new entrant has to prove the quality of its products by supplying to a steel manufacturer and then get referral and word-of-mouth publicity for its products from the manufacturer. Another barrier for new as well as some of the existing players is the high cost of setting up a greenfield graphite electrodes manufacturing facility. Outlook and valuation Global steel production scaled new highs in 2012 and is expected to grow further in the years to come, which bodes well for graphite electrode manufacturers as well. Global players are now operating at high utilization rates of ~77%. Recently, they have also announced price hikes that would allow GIL to follow suit and, hence, benefit GIL s margins. At the CMP, the stock is trading at attractive valuations of 0.9x FY2014E BV. We have valued the stock at its five-year median of 1.2x one-year forward book value to arrive at a target price of `124. We maintain our Buy recommendation on the stock. May 11, 2011 5

Profit and loss (Consolidated) Y/E March FY09 FY10 FY11 FY12 FY13E FY14E Total operating income 1,498 1,347 1,444 1,912 2,158 2,406 % chg 12.6 (10.1) 7.2 32.5 12.8 11.5 Total Expenditure 1,135 950 1,136 1,589 1,768 1,951 Net Raw Materials 487 480 535 775 863 962 Other Mfg costs 381 243 358 443 516 555 Personnel 135 122 131 156 201 224 Other 132 105 112 215 188 210 EBITDA 363 397 308 323 389 455 % chg 30.8 9.3 (22.3) 4.8 20.6 16.8 (% of Net Sales) 24.2 29.5 21.4 17.3 18.1 18.9 Depreciation& Amortisation 44 50 49 49 58 64 EBIT 319 347 260 274 331 391 % chg 34.9 8.7 (25.1) 5.6 20.7 18.1 (% of Net Sales) 21.3 25.7 18.0 14.7 15.3 16.3 Interest & other Charges 35 14 8 19 23 20 Other Income 25 32 34 38 38 38 (% of PBT) 8.2 8.8 12.0 13.0 11.0 9.3 Share in profit of Associates - - - - - - Recurring PBT 309 365 286 294 347 410 % chg 38.6 17.9 (21.4) 2.6 18.0 18.2 Extraordinary Expense/(Inc.) 58 1 13 (3) - - PBT (reported) 251 364 274 297 347 410 Tax 18 129 85 85 104 135 (% of PBT) 7.3 35.5 30.9 28.5 30.0 33.0 PAT (reported) 233 235 189 212 243 274 Add: Share of earnings of asso. - - - - - - Less: Minority interest (MI) - - - - - - Prior period items (1) - - - - - PAT after MI (reported) 233 235 189 212 243 274 ADJ. PAT 234 235 189 212 243 274 % chg 64.5 0.3 (19.5) 12.4 14.2 13.1 (% of Net Sales) 15.6 17.4 13.1 11.4 11.2 11.4 Basic EPS (`) 15.1 13.7 9.7 10.9 12.4 14.0 Fully Diluted EPS (`) 11.5 10.7 9.7 10.9 12.4 14.0 % chg 43.9 (6.6) (9.6) 12.4 14.2 13.1 May 11, 2011 6

Balance sheet (consolidated) Y/E March (` cr) FY09 FY10 FY11 FY12 FY13E FY14E SOURCES OF FUNDS Equity Share Capital 34 34 39 39 39 39 Preference Capital - - - - - - Reserves & Surplus 1,085 1,249 1,483 1,617 1,779 1,974 Shareholders Funds 1,119 1,283 1,522 1,656 1,818 2,013 Minority Interest Total Loans 528 324 341 593 543 443 Deferred Tax Liability (Net) 62 74 62 70 70 70 Total Liabilities 1,709 1,681 1,924 2,319 2,431 2,526 APPLICATION OF FUNDS Gross Block 995 1,010 1,047 1,247 1,347 1,360 Less: Acc. Depreciation 435 485 534 583 641 705 Net Block 559 524 513 664 706 655 Capital Work-in-Progress 14 20 103 65 10 - Goodwill - - - 1 1 1 Investments 101 187 225 250 250 250 Current Assets 1,336 1,230 1,448 1,736 1,945 2,150 Cash 177 80 48 19 22 31 Loans & Advances 132 119 146 187 187 187 Inventories 695 729 906 1,037 1,199 1,337 Debtors 318 291 339 457 502 559 Other 14 11 9 36 36 36 Current liabilities 301 281 364 397 480 530 Net Current Assets 1,035 949 1,084 1,339 1,465 1,620 Mis. Exp. not written off - - - - - - Total Assets 1,709 1,681 1,924 2,319 2,431 2,526 May 11, 2011 7

Cash flow statement (consolidated) Y/E March FY09 FY10 FY11 FY12 FY13E FY14E Profit before tax 251 364 274 297 347 410 Depreciation 44 50 49 49 58 64 (Inc.)/ Dec. in Working Capital (114) (9) (170) (287) (96) (145) Less: Other income - - - - - - Direct taxes paid 18 129 85 85 104 135 Cash Flow from Operations 163 276 68 (26) 205 193 (Inc.)/ Dec. in Fixed Assets (165) (21) (119) (163) (45) (3) (Inc.)/ Dec. in Investments 5 (86) (38) (24) - - (Inc.)/ Dec. in loans and advances - - - - - - Other income - - - - - - Cash Flow from Investing (160) (108) (157) (187) (45) (3) Issue of Equity 4 3 129 - - - Inc./(Dec.) in loans (91) (204) 17 252 (50) (100) Dividend Paid (Incl. Tax) 60 70 80 80 80 80 Interest paid - - - - - - Others 254 7 (8) 11 (27) 0 Cash Flow from Financing 108 (265) 58 184 (157) (180) Inc./(Dec.) in Cash 111 (97) (32) (29) 3 9 Opening Cash balances 66 177 80 48 19 22 Closing Cash balances 177 80 48 19 22 31 May 11, 2011 8

Key ratios (consolidated) Y/E March FY09 FY10 FY11 FY12 FY13E FY14E Valuation Ratio (x) P/E (on FDEPS) 8.1 8.7 9.6 8.5 7.5 6.6 P/E (on basic, reported EPS) 6.1 6.8 9.6 8.5 7.5 6.6 P/CEPS 5.7 5.6 7.6 6.9 6.0 5.4 P/BV 1.4 1.2 1.2 1.1 1.0 0.9 Dividend yield (%) 3.2 3.8 3.8 3.8 3.8 3.8 Market cap. / Sales 1.1 1.2 1.3 0.9 0.8 0.8 EV/Sales 1.1 1.2 1.5 1.1 0.9 0.8 EV/EBITDA 4.5 4.2 6.9 6.5 5.1 4.0 EV / Total Assets 1.0 1.0 1.1 0.9 0.8 0.7 Per Share Data (`) EPS (Basic) 15.1 13.7 9.7 10.9 12.4 14.0 EPS (fully diluted) 11.5 10.7 9.7 10.9 12.4 14.0 Cash EPS 16.2 16.6 12.2 13.4 15.4 17.3 DPS 3.0 3.5 3.5 3.5 3.5 3.5 Book Value 55.1 58.5 77.9 84.7 93.1 103.0 DuPont Analysis (%) EBIT margin 21.3 25.7 18.0 14.3 15.3 16.3 Tax retention ratio 92.7 64.5 69.1 71.5 70.0 67.0 Asset turnover (x) 1.0 1.0 0.9 0.9 1.0 1.1 ROCE (Post Tax) 20.7 15.8 10.9 9.6 10.7 11.7 Cost of Debt (Post Tax) 5.7 2.2 1.6 2.9 2.8 2.7 Leverage (x) 0.3 0.1 0.0 0.1 0.2 0.1 Operating ROE 25.3 17.5 11.2 10.4 12.0 12.6 Returns (%) ROCE (Pre-tax) 20.2 20.5 14.4 12.9 13.9 15.8 ROCE (Post-tax) 1,876.3 1,320.3 995.0 923.7 975.5 1,057.0 ROIC 1,935.6 1,548.7 1,067.0 957.3 1,077.3 1,150.9 Angel ROIC 22.5 24.9 16.8 13.8 15.4 17.4 ROE 25.0 19.6 13.5 13.4 14.0 14.3 Turnover ratios (x) Asset Turnover (Gross Block) 1.6 1.3 1.4 1.7 1.7 1.8 Asset Turnover (Net Block) 2.7 2.5 2.8 3.3 3.2 3.5 Asset Turnover (Total Assets) 1.0 0.8 0.8 0.9 0.9 1.0 Operating Income / Invested Capital 1.1 1.0 0.9 1.0 1.0 1.1 Inventory / Sales (days) 150 193 207 185 189 192 Receivables (days) 89 83 80 76 81 81 Payables (days) 77 79 71 59 64 70 Working capital cycle (ex-cash) (days) 194 234 241 225 234 230 Solvency ratios (x) Gross debt to equity 0.5 0.3 0.2 0.4 0.3 0.2 Net debt to equity 0.2 0.0-0.2 0.1 0.1 Net debt to EBITDA 0.7 0.1-1.0 0.7 0.4 Interest Coverage (EBIT / Interest) 9.1 24.0 33.5 14.7 14.6 19.8 May 11, 2011 9

Research Team Tel: 022-39357800 E-mail: research@angelbroking.com Website: www.angelbroking.com DISCLAIMER This document is solely for the personal information of the recipient, and must not be singularly used as the basis of any investment decision. Nothing in this document should be construed as investment or financial advice. Each recipient of this document should make such investigations as they deem necessary to arrive at an independent evaluation of an investment in the securities of the companies referred to in this document (including the merits and risks involved), and should consult their own advisors to determine the merits and risks of such an investment. Angel Broking Limited, its affiliates, directors, its proprietary trading and investment businesses may, from time to time, make investment decisions that are inconsistent with or contradictory to the recommendations expressed herein. The views contained in this document are those of the analyst, and the company may or may not subscribe to all the views expressed within. Reports based on technical and derivative analysis center on studying charts of a stock's price movement, outstanding positions and trading volume, as opposed to focusing on a company's fundamentals and, as such, may not match with a report on a company's fundamentals. The information in this document has been printed on the basis of publicly available information, internal data and other reliable sources believed to be true, but we do not represent that it is accurate or complete and it should not be relied on as such, as this document is for general guidance only. Angel Broking Limited or any of its affiliates/ group companies shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. Angel Broking Limited has not independently verified all the information contained within this document. Accordingly, we cannot testify, nor make any representation or warranty, express or implied, to the accuracy, contents or data contained within this document. While Angel Broking Limited endeavours to update on a reasonable basis the information discussed in this material, there may be regulatory, compliance, or other reasons that prevent us from doing so. This document is being supplied to you solely for your information, and its contents, information or data may not be reproduced, redistributed or passed on, directly or indirectly. Angel Broking Limited and its affiliates may seek to provide or have engaged in providing corporate finance, investment banking or other advisory services in a merger or specific transaction to the companies referred to in this report, as on the date of this report or in the past. Neither Angel Broking Limited, nor its directors, employees or affiliates shall be liable for any loss or damage that may arise from or in connection with the use of this information. Note: Please refer to the important `Stock Holding Disclosure' report on the Angel website (Research Section). Also, please refer to the latest update on respective stocks for the disclosure status in respect of those stocks. Angel Broking Limited and its affiliates may have investment positions in the stocks recommended in this report. Disclosure of Interest Statement Graphite India 1. Analyst ownership of the stock No 2. Angel and its Group companies ownership of the stock No 3. Angel and its Group companies' Directors ownership of the stock No 4. Broking relationship with company covered No Note: We have not considered any Exposure below ` 1 lakh for Angel, its Group companies and Directors Ratings (Returns): Buy (> 15%) Accumulate (5% to 15%) Neutral (-5 to 5%) Reduce (-5% to -15%) Sell (< -15%) May 11, 2011 10